Can the new humanized mouse model give HIV research a boost.
Shacklett
Barbara L
BL
Department of Medical Microbiology and Immunology, Division of Infectious Diseases, School of Medicine, University of California, Davis, Davis, California, United States of America.
D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000282:Administration, Intravaginal; D000818:Animals; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004195:Disease Models, Animal; D004198:Disease Susceptibility; D004353:Drug Evaluation, Preclinical; D000068679:Emtricitabine; D005260:Female; D015658:HIV Infections / Q000517:prevention & control / Q000635:transmission*; D015497:HIV-1; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016031:Liver Transplantation; D008253:Macaca mulatta; D051379:Mice; D016688:Mice, Inbred NOD; D008815:Mice, Inbred Strains; D016513:Mice, SCID; D063065:Organophosphonates / Q000627:therapeutic use; D011828:Radiation Chimera; D013045:Species Specificity; D000068698:Tenofovir; D013950:Thymus Gland / Q000637:transplantation; D014183:Transplantation, Heterologous
D063065:Organophosphonates; D003841:Deoxycytidine; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine